home.aspx
 
EVENTS

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

Axio Research

With over 35 years of experience, Axio is a premier provider of biostatistics services to pharmaceutical and biotechnology companies. Axio is widely recognized as world-leading provider of Data Monitoring Committee (DMC) support services, having supported clients in the planning and management of more than 300 DMCs across all major therapeutic areas.

RELATED NEWS


NICE has said MSD’s cancer immunotherapy, Keytruda, should receive interim funding on the NHS in certain patients with untreated lung cancer, in combination with chemotherapy. In the first draft guidance, NICE said Keytruda (pembrolizumab) will be reimbursed by the Cancer Drugs Fund, with pemetrexed and platinum chemotherapy, for adults with untreated non-squamous non-small cell lung cancer. Their tumors must have no epidermal growth factor receptor (EGFR) or anaplastic lymphoma mutations....

READ MORE

Emflaza’s active ingredient is deflazacort, an old steroid that families were using off-label to treat symptoms of DMD in boys affected by the genetic disease....
RICHARD STAINES
READ MORE

A small biotech, MacroGenics, took the market by surprise earlier this year with some surprising data from its margetuximab essentially a tweaked version of Roche’s Herceptin (trastuzumab) where a few amino acid mutations are enough to produce a stronger cellular response to cancer.CEO Scott Koenig has been doing the rounds at the American Society of Clinical Oncology (ASCO) conference in Chicago following release of detailed data from the SOPHIA trial of margetuximab in breast cancer pati...

READ MORE

She’s a multi award-winning pharmacist and shares a name (almost) with the federal health minister. And now Susan Lee has been crowned Tasmanian pharmacist of the year for 2016. Over almost two.....
PHARMACYNEWS.COM.
READ MORE

Kerri O’Keefe had worked as a care aide in the emergency department at Vancouver General Hospital (VGH), in British Columbia, for more than 15 years, transporting patients and helping them with all their basic needs....

READ MORE

Global and China Chemotherapy Induced Peripheral Neuropathy Treatment Market Research by Company, Type & Application 2013-2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing capital structure of the Global and China Chemotherapy Induced Peri...

READ MORE

EVENTS

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...